|
Press Releases |
|
|
|
Thursday, August 27, 2020 |
|
李氏大药厂公布2020中期业绩 |
结合研究主导和市场导向的中国药品制造公司 - 李氏大药厂控股有限公司 (「李氏大药厂」或「集团」;股票编号︰950),今天宣布截至2020年6月30日止(「回顾期内」)的中期业绩。 more info >> |
|
李氏大藥廠公佈2020中期業績 |
結合研究主導和市場導向的中國藥品製造公司 - 李氏大藥廠控股有限公司 (「李氏大藥廠」或「集團」;股票編號︰950),今天宣佈截至2020年6月30日止(「回顧期內」)的中期業績。 more info >> |
|
Lee's Pharm Announces 2020 Interim Results |
Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group"; HKG: 950), an integrated research-driven and market-oriented pharmaceutical group in China, today announced its interim results for the six months ended 30 June 2020 (the "period under review"). more info >> |
|
Thursday, November 28, 2019 |
|
李氏大药厂公布2019年第三季度业绩 |
结合研究主导和市场导向的中国药品制造公司- 李氏大药厂控股有限公司(「李氏大药厂」或「集团」;股票编号︰950),今天宣布截至2019年9月30日止九个月(「回顾期内」)之未经审核综合季度财务业绩。 more info >> |
|
李氏大藥廠公佈2019年第三季度業績 |
結合研究主導和市場導向的中國藥品製造公司 - 李氏大藥廠控股有限公司 (「李氏大藥廠」或「集團」;股票編號︰950),今天宣佈截至2019年9月30日止九個月(「回顧期內」)之未經審核綜合季度財務業績。 more info >> |
|
Lee's Pharm Announces 2019 Third Quarterly Results |
Lee's Pharmaceutical Holdings Limited ("Lee's Pharm" or the "Group", Stock Code: 950), an integrated research-driven and market-oriented pharmaceutical group in China, today announced its unaudited consolidated quarterly financial results for the nine months ended 30 September 2019 (the "period under review"). more info >> |
|
Thursday, October 31, 2019 |
|
COPFL宣布其全资附属公司ZKO自主研发的产品环孢霉素A眼科凝胶的II期临床研究已完满完成 |
China Ophthalmology Focus Limited(「COPFL」)今天宣布,其全资附属公司兆科(广州)眼科药物有限公司(「ZKO」) 自主研发的产品环孢霉素A眼科凝胶的II期临床研究已完满完成(clinicaltrials.gov登记号码:NCT03676335)。顶线数据显示,与市售环孢霉素A眼科乳剂相比,实验药物具有相似或更好的疗效趋势。 more info >> |
|
COPFL宣布其全資附屬公司ZKO自主研發的產品環孢霉素A眼科凝膠的II期臨床研究已完滿完成 |
China Ophthalmology Focus Limited(「COPFL」)今天宣布,其全資附屬公司兆科(廣州)眼科藥物有限公司(「ZKO」) 自主研發的產品環孢霉素A眼科凝膠的II期臨床研究已完滿完成(clinicaltrials.gov登記號碼:NCT03676335)。頂線數據顯示,與市售環孢霉素A眼科乳劑相比,實驗藥物具有相似或更好的療效趨勢。 more info >> |
|
COPFL announced that its wholly-owned subsidiary-ZKO, has successfully completed a Phase II trial of Cyclosporine A Ophthalmic Gel |
China Ophthalmology Focus Limited ("COPFL") today announced that its wholly-owned subsidiary, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited ("ZKO"), has successfully completed a Phase II trial of Cyclosporine A (CsA) Ophthalmic Gel in China (clinicaltrials.gov registration No.:NCT03676335). Topline data show that the experimental drug has similar or a trend towards better efficacy than that of the marketed CsA Ophthalmic Emulsion. more info >> |
|
Thursday, March 28, 2019 |
|
李氏大药厂公布2018年全年业绩 |
结合研究主导和市场导向的中国药品制造公司-李氏大药厂控股有限公司(「李氏大药厂」或「集团」;股票编号︰950),今天宣布截至2018年12月31日止的全年业绩(「回顾年内」)。 more info >> |
|
|
|
|
|
|
|
|
Latest Press Releases |
|
Paltalk to Host First Quarter 2024 Earnings Results Conference Call on Thursday, May 9, 2024 at 9:00 a.m. ET
May 2, 2024 00:28 HKT/SGT
|
|
|
PodcastOne (Nasdaq: PODC) Acquires Exclusive Sales and Distribution Rights to Dumb Gay Podcast
May 2, 2024 00:19 HKT/SGT
|
|
|
Forian Inc. to Announce First Quarter 2024 Results on May 14, 2024
May 2, 2024 00:09 HKT/SGT
|
|
|
Vietnam to Rethink Financial Services After a Cutting-edge Show at WFIS
May 1, 2024 16:42: JST
|
|
|
Vietnam to Rethink Financial Services After a Cutting-edge Show at WFIS
May 1, 2024 15:42 HKT/SGT
|
|
|
国美金融科技发布2023年度报告 商业保理稳中向好 多元化协同发展
May 1, 2024 13:18 HKT/SGT
|
|
|
國美金融科技發佈2023年度報告 商業保理穩中向好 多元化協同發展
May 1, 2024 13:12 HKT/SGT
|
|
|
Anson Resources Signs Lithium Supply Agreement with LG Energy Solution
May 1, 2024 09:00 HKT/SGT
|
|
|
The 16th Annual Global CSR & ESG Summit and Awards 2024: Celebrating Sustainable Leadership and Innovation, 25 April 2024
Apr 30, 2024 19:40 HKT/SGT
|
|
|
Q2 Metals Announces Completion of Drill-Core Re-Evaluation for the Cisco Lithium Property, James Bay Territory, Quebec, Canada
Apr 30, 2024 19:09 HKT/SGT
|
|
|
Sumitomo Metal Mining and Mitsubishi Corporation to Participate in Kalgoorlie Nickel Project - Goongarrie Hub
Apr 30, 2024 19:08 JST
|
|
|
Hong Kong Gifts, printing and packaging, and licensing events foster cross-industry opportunities
Apr 30, 2024 18:00 HKT/SGT
|
|
|
Moolec Announces New Patent Granting in the United States for Molecular Farming Platform
Apr 30, 2024 18:00 HKT/SGT
|
|
|
DCCI fortifies stance for Malaysia's greatest show: Wins support from key government organisations
Apr 30, 2024 17:56 HKT/SGT
|
|
|
New Immuno-Oncology Research Project in Partnership With Merck Starts at the BioMed X Institute in Heidelberg
Apr 30, 2024 18:00 JST
|
|
|
|
More News >> |
|
|
|
|
|